F517-0013 Screening compound: 2-bromo-N-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide

F517-0013 Screening compound: 2-bromo-N-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide
F517-0013 Screening compound: 2-bromo-N-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F517-0013
2-bromo-N-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F517-0013

Molecular Formula

C14H10BrN5O (C14 H10 BrN5 O)

Compound Name

2-bromo-N-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide

IUPAC name

2-bromo-N-[3-(1H-1234-tetrazol-1-yl)phenyl]benzamide

SMILES

O=C(c(cccc1)c1Br)Nc1cc(-n2nnnc2)ccc1

InChI

InChI=1S/C14H10BrN5O/c15-13-7-2-1-6-12(13)14(21)17-10-4-3-5-11(8-10)20-9-16-18-19-20/h1-9H,(H,17,21)

InChI Key

UVYRRMBIVOQNAI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD07438642

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

344.17

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.692

Distribution Coefficient, logD

2.691

Water Solubility, LogSw

-3.63

Polar Surface Area

63.095

Acid Dissociation Constant (pKa)

10.68

Base Dissociation Constant (pKb)

-1.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

F517-0013 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F517-0013 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F517-0013?
Check Price and Availability of F517-0013, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F517-0013 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F517-0013
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F517-0013
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F517-0013 available by request